anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Chimerix · conference-presentation

Chimerix | Mergers and Acquisitions Presentation Deck | 26 slides

26 pages · 0 arc beats · 0 loops

Conference-Presentation Download JSON
Unlock

Chimerix | Mergers and Acquisitions Presentation Deck | 26 slides

Chimerix · 2021-01
arc beats above · slides in the middle · loops below · scroll → 0 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

1
coverage by narrative range · generated from this deck JSON
Narrative range 26 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Whole deck 26 slides 100% 26/26 slides 100% 26/26 slides · 108 hits
— 0/26 slides
50% 13/26 slides 23.1% 6/26 slides
— 0/26 slides
— 0/26 slides

Slide inventory

26
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
front_matter
Open slide detail
03
The slide uses a horizontal bar chart format to represent clinical trial phases.present_solution
Open slide detail
04
quantify_opportunity
Open slide detail
05
The chart is a bubble plot showing median overall survival across various trials, with bubble size representing patient count.diagnose_problem
Open slide detail
06
size_opportunity
Open slide detail
07
Waterfall plot shows 47 subjects; 3 subjects excluded from plot due to lack of on-treatment assessments.analyze_data
Open slide detail
08
The chart is a spider plot (or spaghetti plot) tracking individual patient tumor burden over time.analyze_data
Open slide detail
09
illustrate_case
Open slide detail
10
The slide uses a before-after-during visual sequence of MRI scans to demonstrate treatment efficacy.illustrate_case
Open slide detail
11
The slide uses a Kaplan-Meier curve on the left and a bubble plot on the right to visualize the survival advantage.compare_peers
Open slide detail
12
The table displays Treatment-Emergent Adverse Events (TEAEs) for 30 patients.analyze_data
Open slide detail
13
Includes a BioRender diagram illustrating the molecular pathway.present_framework
Open slide detail
14
Includes molecular mechanism diagram, bar chart of DRD2 expression, PET scan images, and dot plot of IC50 values.analyze_data
Open slide detail
15
The chart is a classic waterfall plot used in oncology to show individual patient response.analyze_data
Open slide detail
16
Mentions specific regulatory bodies (FDA, EMA) and clinical criteria (cIMPACT NOW, RANO-HGG).summarize
Open slide detail
17
establish_context
Open slide detail
18
other
Open slide detail
19
Includes specific breakdown of upfront consideration, milestone payments, and royalty structures.other
Open slide detail
20
summarize
Open slide detail
21
transition
Open slide detail
22
summarize
Open slide detail
23
Uses a Gantt-style chart to show drug development progress.summarize
Open slide detail
24
The slide uses a matrix-like layout to contrast past performance with future expectations.plan_implementation
Open slide detail
25
summarize
Open slide detail
26
front_matter
Open slide detail